FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892353002> ?p ?o ?g. }

• W2892353002 endingPage "1411" @default.
• W2892353002 startingPage "1401" @default.
• W2892353002 abstract "A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile Federica Brosio,1 Giulia Masetti,1 Giulio Matteo,1 Armando Stefanati,2 Giovanni Gabutti2 1Postgraduate School of Hygiene and Preventive Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy; 2Department of Medical Sciences, University of Ferrara, Ferrara, Italy Abstract: Herpes zoster (HZ) is an acute vesicular dermatitis with a typical dermatomal distribution, caused by the varicella zoster virus (VZV), often preceded and accompanied by prodromal pain or pruritus. HZ may be related to several complications such as postherpetic neuralgia (PHN). The incidence and severity of the disease increase with aging, due to immunosenescence and in particular to the decline of the specific cell-mediated immunity (CMI). The impact of HZ in terms of morbidity and short- and long-term complications, the availability of suboptimal treatment options to date, and the high costs for the diagnostic and clinical-therapeutic management of patients have motivated the search for a new preventive approach through the development of a vaccine. The vaccine currently in use with live-attenuated virus (ZVL) has been shown to be effective in reducing the incidence of HZ, its impact, and the onset of PHN, although the efficacy is lower in older subjects and tends to decrease some years after immunization. A new adjuvanted recombinant subunit vaccine (HZ/su), containing the VZV glycoprotein E (gE) and the AS01B adjuvant system, is now a very promising alternative to ZVL; in several clinical studies, it showed a good safety profile and was able to elicit high immune humoral and cell-mediated responses, both maintained up to 9 years. Furthermore, HZ/su vaccine was effective both in preventing HZ and in reducing the onset of PHN and other complications. HZ/su has been recommended and preferred over ZVL by the Advisory Committee on Immunization Practices (ACIP) for the prevention of HZ and its complications in immunocompetent adults aged ≥50 years, even if already vaccinated with ZVL, through a two-dose schedule. HZ/su has been approved in Canada, USA, Europe, and Japan and is currently being approved in Australia. The aim of this review was to describe the epidemiological data, HZ and PHN risks and their impact on the social life and common life of infected people, and ZVL and HZ/su vaccine development including various clinical trials and efficacy, safety, and tolerability profiles. Keywords: herpes zoster, adjuvanted recombinant herpes zoster subunit vaccine, live-attenuated herpes zoster vaccine" @default.
• W2892353002 created "2018-09-27" @default.
• W2892353002 creator A5014795161 @default.
• W2892353002 creator A5016168231 @default.
• W2892353002 creator A5017300468 @default.
• W2892353002 creator A5028244039 @default.
• W2892353002 creator A5035418203 @default.
• W2892353002 date "2018-09-01" @default.
• W2892353002 modified "2023-10-01" @default.
• W2892353002 title "A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile" @default.
• W2892353002 cites W1496000468 @default.
• W2892353002 cites W1967331460 @default.
• W2892353002 cites W2004718706 @default.
• W2892353002 cites W2005786760 @default.
• W2892353002 cites W2010207831 @default.
• W2892353002 cites W2011226248 @default.
• W2892353002 cites W2011416758 @default.
• W2892353002 cites W2015910336 @default.
• W2892353002 cites W2025539921 @default.
• W2892353002 cites W2040947756 @default.
• W2892353002 cites W2042582875 @default.
• W2892353002 cites W2055629718 @default.
• W2892353002 cites W2085050972 @default.
• W2892353002 cites W2089359789 @default.
• W2892353002 cites W2113361550 @default.
• W2892353002 cites W2115885093 @default.
• W2892353002 cites W2123574813 @default.
• W2892353002 cites W2125575192 @default.
• W2892353002 cites W2130875526 @default.
• W2892353002 cites W2131041950 @default.
• W2892353002 cites W2132796518 @default.
• W2892353002 cites W2141655221 @default.
• W2892353002 cites W2145061830 @default.
• W2892353002 cites W2149820050 @default.
• W2892353002 cites W2152734304 @default.
• W2892353002 cites W2168763662 @default.
• W2892353002 cites W2173387046 @default.
• W2892353002 cites W2173567717 @default.
• W2892353002 cites W2177389296 @default.
• W2892353002 cites W2180922569 @default.
• W2892353002 cites W2215796543 @default.
• W2892353002 cites W2260310536 @default.
• W2892353002 cites W2329705186 @default.
• W2892353002 cites W2338472944 @default.
• W2892353002 cites W2405449700 @default.
• W2892353002 cites W249434667 @default.
• W2892353002 cites W2519957152 @default.
• W2892353002 cites W2561886913 @default.
• W2892353002 cites W2569903330 @default.
• W2892353002 cites W2593752326 @default.
• W2892353002 cites W2594715911 @default.
• W2892353002 cites W2612205165 @default.
• W2892353002 cites W2613019180 @default.
• W2892353002 cites W2625937842 @default.
• W2892353002 cites W2657185040 @default.
• W2892353002 cites W2734800292 @default.
• W2892353002 cites W2737108166 @default.
• W2892353002 cites W2760376241 @default.
• W2892353002 cites W2760564386 @default.
• W2892353002 cites W2769572231 @default.
• W2892353002 cites W2778116823 @default.
• W2892353002 cites W2781747798 @default.
• W2892353002 cites W2784682748 @default.
• W2892353002 cites W2789400684 @default.
• W2892353002 cites W2789983511 @default.
• W2892353002 cites W2794235967 @default.
• W2892353002 cites W2794364315 @default.
• W2892353002 cites W2799818587 @default.
• W2892353002 cites W2808431907 @default.
• W2892353002 cites W2811504119 @default.
• W2892353002 cites W4292496406 @default.
• W2892353002 doi "https://doi.org/10.2147/idr.s148303" @default.
• W2892353002 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6130298" @default.
• W2892353002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30233219" @default.
• W2892353002 hasPublicationYear "2018" @default.
• W2892353002 type Work @default.
• W2892353002 sameAs 2892353002 @default.
• W2892353002 citedByCount "8" @default.
• W2892353002 countsByYear W28923530022018 @default.
• W2892353002 countsByYear W28923530022019 @default.
• W2892353002 countsByYear W28923530022020 @default.
• W2892353002 countsByYear W28923530022021 @default.
• W2892353002 crossrefType "journal-article" @default.
• W2892353002 hasAuthorship W2892353002A5014795161 @default.
• W2892353002 hasAuthorship W2892353002A5016168231 @default.
• W2892353002 hasAuthorship W2892353002A5017300468 @default.
• W2892353002 hasAuthorship W2892353002A5028244039 @default.
• W2892353002 hasAuthorship W2892353002A5035418203 @default.
• W2892353002 hasBestOaLocation W28923530021 @default.
• W2892353002 hasConcept C120665830 @default.
• W2892353002 hasConcept C121332964 @default.
• W2892353002 hasConcept C126322002 @default.
• W2892353002 hasConcept C142724271 @default.
• W2892353002 hasConcept C16005928 @default.
• W2892353002 hasConcept C203014093 @default.
• W2892353002 hasConcept C204787440 @default.
• W2892353002 hasConcept C2522874641 @default.
• W2892353002 hasConcept C2776159415 @default.

• next